Nature Communications (May 2021)

A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation

  • Sisi Kang,
  • Mei Yang,
  • Suhua He,
  • Yueming Wang,
  • Xiaoxue Chen,
  • Yao-Qing Chen,
  • Zhongsi Hong,
  • Jing Liu,
  • Guanmin Jiang,
  • Qiuyue Chen,
  • Ziliang Zhou,
  • Zhechong Zhou,
  • Zhaoxia Huang,
  • Xi Huang,
  • Huanhuan He,
  • Weihong Zheng,
  • Hua-Xin Liao,
  • Fei Xiao,
  • Hong Shan,
  • Shoudeng Chen

DOI
https://doi.org/10.1038/s41467-021-23036-9
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 11

Abstract

Read online

While SARS-CoV-2 S protein targeting monoclonal antibodies (mAbs) are well studied, little is known about N protein-targeting mAbs. Here, Kang et al. provide the crystal structure of the N protein RNA binding domain with a mAb derived from a convalescent patient and show that it compromises the N protein-induced complement hyperactivation.